Literature DB >> 1178820

The aetiology of senile osteoporosis: secondary hyperparathyroidism due to renal failure.

G M Berlyne, J Ben-Ari, A Kushelevsky, A Idelman, D Galinsky, M Hirsch, R Shainkin, R Yagil, M Zlotnik.   

Abstract

The aetiology of senile osteoporosis was investigated in a series of elderly normal persons (mean age 76.8 years) who were compared to 18-19 year old normal controls. Osteoporosis was estimated by standard radiological morphometric and densitometric techniques, in the metacarpals and thoraco-lumbar vertebrae. Serum parathyroid hormone levels were significantly higher in the elderly group, and correlated well with morphometric and densometric measurements of osteoporosis. Creatinine clearance was reduced in seven out of nine of the elderly group, and correlated well with the degree of osteoporosis. Serum thyrocalcitonin levels were reduced in the elderly. Tubular reaborption of phosphate and TmP/GFR were in the hyperparathyroid range in the elderly group and correlated well with the degree of osteoporosis. The hypothesis is advanced that the osteoporosis of old age is a result of parathyroid overactivity, caused by asymptomatic chronic renal failure. The suggestion is made that a diet low in phosphorus might reduce the incidence of osteoporosis in old age by reducing the parathyroid overactivity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1178820

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  14 in total

1.  Bone disease in the elderly.

Authors:  R Smith
Journal:  Proc R Soc Med       Date:  1976-12

2.  The management of osteoporosis.

Authors:  A N Exton-Smith
Journal:  Proc R Soc Med       Date:  1976-12

3.  Serum bone gla protein (BGP) and other markers of bone mineral metabolism in postmenopausal osteoporosis.

Authors:  F Ismail; S Epstein; R Pacifici; D Droke; S B Thomas; L V Avioli
Journal:  Calcif Tissue Int       Date:  1986-10       Impact factor: 4.333

4.  Parathyroid hormone secretion and 25-hydroxyvitamin D levels in primary osteoporosis.

Authors:  J Dequeker; R Bouillon
Journal:  Calcif Tissue Res       Date:  1977-05

5.  99mTc-MDP retention in osteoporosis: relationship to other indices of bone cell activity and response to calcium and vitamin D therapy.

Authors:  M W Davie; J M Britton; M Haddaway; I W McCall
Journal:  Eur J Nucl Med       Date:  1987

6.  The use of sodium fluoride, vitamin D and calcium supplements in the treatment of patients with axial osteoporosis.

Authors:  V Parsons; C J Mitchell; J Reeve; R Hesp
Journal:  Calcif Tissue Res       Date:  1977-05

7.  Trpv6 mediates intestinal calcium absorption during calcium restriction and contributes to bone homeostasis.

Authors:  L Lieben; B S Benn; D Ajibade; I Stockmans; K Moermans; M A Hediger; J B Peng; S Christakos; R Bouillon; G Carmeliet
Journal:  Bone       Date:  2010-04-24       Impact factor: 4.398

8.  Parathyroid hormone and 25-hydroxyvitamin D concentrations in the elderly.

Authors:  G M Berlyne
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-05

9.  Parathyroid hormone and 25-hydroxyvitamin D concentrations in sick and normal elderly people.

Authors:  M M Petersen; R S Briggs; M A Ashby; R I Reid; M R Hall; P J Wood; B E Clayton
Journal:  Br Med J (Clin Res Ed)       Date:  1983-08-20

10.  Lack of hormonal changes in postmenopausal women of equal weight with and without osteoporosis, including relation to time of menopause.

Authors:  H Rico; A Charro; I Depablos; E Bordiu; E R Hernandez; D Espinos
Journal:  Clin Rheumatol       Date:  1984-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.